New Cedars-Sinai Study Investigates Shifting Trends in GLP-1RA Prescription

Investigators at Cedars-Sinai and other institutions conducted a nationwide, population-based study to identify trends in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs)—prescription medications sold under popular drug names like Ozempic and Wegovy—in the United States.

Cedars-Sinai Again Ranked in Top Tier of U.S. Hospitals

Cedars-Sinai has been named to the Honor Roll for the ninth consecutive year in U.S. News & World Report’s “Best Hospitals 2024-25” rankings.

Black and Hispanic Women Receive Lower Doses of Postpartum Pain Medication, According to New Study

Inequities in pain medication treatment received postpartum, after giving birth, were found in a Cedars-Sinai study of 18,000 women. The disparities were observed even among patients reporting the highest pain levels.

Lali Medina-Kauwe, PhD, Named Associate Dean of Cedars-Sinai PhD Programs

Lali Medina-Kauwe, PhD, a nationally regarded expert in molecular engineering and nanoparticle cancer research, has been named associate dean of PhD programs and director of the PhD program in Biomedical and Translational Sciences at Cedars-Sinai.

Q&A: New Frontiers in ALS Research

Clive Svendsen, PhD, executive director of the Board of Governors Regenerative Medicine Institute and professor of Medicine and Biomedical Sciences at Cedars-Sinai, is developing new treatments and models for amyotrophic lateral sclerosis (ALS) using stem cells.

Cedars-Sinai Pulmonary and Critical Care Experts Present Latest Research at International Conference

Cedars-Sinai experts in pulmonology, critical care medicine and lung transplant attending the May 17-22 American Thoracic Society’s (ATS) 2024 International Conference in San Diego are available to comment on scientific advances being presented throughout the conference.

Cedars-Sinai’s Chief Health Equity Officer Available for Interviews During AHA Health Equity Conference

Cedars-Sinai’s chief health equity officer will be available for interviews during the American Hospital Association: Accelerating Health Equity Conference, May 7-9 in Kansas City.

Women’s Health Month: Artificial Intelligence Can Improve OB-GYN Care

Cedars-Sinai investigators are using artificial intelligence (AI) to reduce serious health risks associated with pregnancy and childbirth and improve screening for some gynecological cancers.

Cedars-Sinai Physician-Scientist Leads Association of American Physicians

Paul Noble, MD, professor of Medicine at Cedars-Sinai and a leading physician-scientist in pulmonary fibrosis, recently began his one-year term as president of the highly regarded Association of American Physicians (AAP) at the group’s annual meeting in Chicago.

Artificial Intelligence Can Evaluate Cardiovascular Risk During CT Scan

A recent study designed and implemented by investigators at Cedars-Sinai found that artificial intelligence (AI) can accurately evaluate cardiovascular risk during a routine chest computed tomography (CT) scan without contrast.

Cedars-Sinai Lanza Atención Médica Virtual Para Niños e Hispanohablantes

Cedars-Sinai está ampliando la atención médica virtual para niños e hispanohablantes en California a través de su aplicación móvil Cedars-Sinai Connect, una opción en línea de rápido crecimiento que permite a los pacientes acceder rápidamente a los mejores profesionales sanitarios para la atención aguda, crónica y preventiva.

Cedars-Sinai Joins 40 Health Systems in White House Effort on AI

Cedars-Sinai has joined a White House initiative aimed at ensuring healthcare providers and companies use artificial intelligence (AI) ethically and responsibly. Together with the U.S. Department of Health and Human Services, the AI effort—announced in late 2023—is a consortium involving nearly 40 health systems and insurers.

Curtis L. Cetrulo, Jr., MD, Selected as Lyon Family Chair in Plastic Surgery

Curtis L. Cetrulo Jr., MD, vice chair of Research in the Department of Surgery and director of the Division of Plastic Surgery, has been selected as the General William and Willa Dean Lyon Family Chair in Reconstructive and Plastic Surgery.

Endometriosis Awareness Month: Answers to Frequently Asked Questions

It is one of the most common and painful disorders, affecting more than 6 million women in the United States. Endometriosis is often difficult to diagnose and effectively treat. But Cedars-Sinai experts find patients can now benefit from minimally invasive procedures, medications and integrative medicine.

The Time Is Now for Artificial Intelligence, Machine Learning

From artificial intelligence (AI) and data integration to natural language processing and statistics, the Cedars-Sinai Department of Computational Biomedicine is utilizing the latest technological advances to find solutions to some of the most complex healthcare issues.

Genetics, Sex and Smoking Linked to More Health Issues for IBD Patients

Investigators at Cedars-Sinai have identified risk factors that make inflammatory bowel disease (IBD) patients susceptible to developing serious conditions in other parts of their bodies.

Cedars-Sinai Names Vice Dean of Medical Education

Laurence Katznelson, MD, a national leader in graduate medical education and a distinguished physician-scientist in endocrinology and metabolism, will join Cedars-Sinai as vice dean of Medical Education on May 1.

Joint Accreditation Expands Cedars-Sinai’s Interprofessional Continuing Education

The Continuing Medical Education program at Cedars-Sinai has earned Joint Accreditation with Commendation, enhancing continuing education opportunities for healthcare professionals and signifying that Cedars-Sinai upholds the highest standards in providing relevant, effective, practice-based education.

RESEARCH ALERT: The New Geography of the Gut

Investigators from Cedars-Sinai; the University of California, San Francisco (UCSF); Harvard University; and the Weizmann Institute of Science in Israel conducted a study to determine where individual nutrients are absorbed in the small intestine. For the first time, they identified the molecular markers that define five distinct intestinal regions.

Cedars-Sinai High-Risk Pregnancy Experts Share Latest Research at Annual Scientific Meeting

High-risk pregnancy specialists from Cedars-Sinai will share their research findings at the Society for Maternal-Fetal Medicine 2024 Pregnancy Meeting, Feb.10-14, in National Harbor, Maryland.

Cedars-Sinai Stroke Experts Present Latest Research at International Stroke Conference Feb. 6-9

Physician-scientists from the Comprehensive Stroke Center at Cedars-Sinai will be attending the International Stroke Conference Feb. 6-9 in Phoenix and are available to discuss the latest stroke news and research.

3rd Space Launch of Cedars-Sinai Stem Cells Slated for Jan. 29

Cedars-Sinai and Space Tango are planning their third launch of pilot-scale systems for the automated in-space production of stem cells to the International Space Station.

Adult Congenital Heart Surgery Team Saves a Life, Sparks an Idea

She was five days postpartum. Her first child was a perfect baby girl. What was supposed to be among the happiest times in Marisa Dominguez’s life was, instead, the scariest.

Cedars-Sinai Infectious Disease Experts Featured at IDWeek Meeting

Cedars-Sinai infectious disease specialists and investigators will present research and discuss clinical advances throughout IDWeek, taking place in Boston from Oct. 11-15.

Cedars-Sinai Expert Selected to Lead California Maternal Health Panel

Cedars-Sinai maternal-fetal medicine leader Kimberly Gregory, MD, MPH, is the new chair of the California Pregnancy-Associated Review Committee (CA-PARC).

Cedars-Sinai Welcomes New Plastic Surgery Leader

Cedars-Sinai has selected Curtis L. Cetrulo Jr., MD, as the new vice chair of Research in the Department of Surgery, director of the Division of Plastic Surgery and director of Vascularized Composite Allotransplantation Program Development.